1500003O22Rik Inhibitors
Chemical inhibitors of protein 1500003O22Rik target various signaling pathways to inhibit its activity. Staurosporine, a broad-spectrum protein kinase inhibitor, binds to the ATP binding site of kinases, thus preventing ATP from binding and disabling the kinase's activity. This direct inhibition can halt the phosphorylation process that is necessary for protein 1500003O22Rik's function. Similarly, Bisindolylmaleimide I and Go6983, both known for inhibiting protein kinase C (PKC), can reduce the activity of downstream kinases, which would include protein 1500003O22Rik if it is affected by PKC-mediated phosphorylation. LY294002 and Wortmannin, as inhibitors of PI3K, work upstream in the signaling pathway to prevent the activation of protein 1500003O22Rik by obstructing PI3K-dependent signaling routes.
Further down the line of kinase signaling, Rapamycin, by inhibiting mTOR, can suppress the phosphorylation and activation of several downstream proteins, potentially including protein 1500003O22Rik. PD98059 and U0126, both targeting MEK within the MAPK/ERK pathway, prevent the kinase cascade that could lead to the activation of protein 1500003O22Rik. SB203580 and SP600125 inhibit p38 MAP kinase and JNK, respectively, which disrupts signaling pathways that are essential for the function of various downstream proteins, possibly including protein 1500003O22Rik. PP2, which is a Src family tyrosine kinase inhibitor, can inhibit the activity of protein 1500003O22Rik by blocking Src kinase activity, which may be crucial for the protein's activation. Lastly, Y-27632, a selective inhibitor of ROCK, can suppress the function of protein 1500003O22Rik if it is a part of the ROCK signaling pathway. Each of these inhibitors acts by either directly targeting protein 1500003O22Rik or by impeding upstream signaling events that are essential for its activation.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent inhibitor of protein kinases. Protein 1500003O22Rik, being a kinase, would be inhibited by staurosporine as it blocks the ATP binding site, necessary for kinase activity. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I targets protein kinase C (PKC). Given that protein 1500003O22Rik is a kinase, the inhibition of PKC can lead to decreased activation of downstream kinases including protein 1500003O22Rik. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a specific inhibitor of phosphoinositide 3-kinases (PI3Ks). If protein 1500003O22Rik is downstream of PI3K signaling, LY294002 would inhibit its activation by preventing PI3K-mediated signaling events. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits the mammalian target of rapamycin (mTOR), a key regulatory kinase. Inhibition of mTOR can lead to reduced phosphorylation and activation of downstream proteins, which may include protein 1500003O22Rik if it is part of the mTOR signaling pathway. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 selectively inhibits mitogen-activated protein kinase kinase (MEK), which is part of the MAPK/ERK pathway. Protein 1500003O22Rik, if regulated by this pathway, would be inhibited due to blockade of MEK and subsequent signaling cascade. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a specific inhibitor of p38 MAP kinase. If protein 1500003O22Rik operates downstream of the p38 MAPK pathway, its activity would be inhibited due to the blockade of p38 MAPK signaling. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of c-Jun N-terminal kinase (JNK). If protein 1500003O22Rik is a part of JNK signaling, inhibition by SP600125 would prevent its activation through this pathway. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another inhibitor of PI3K. Inhibition of PI3K by wortmannin would prevent activation of downstream proteins, potentially including protein 1500003O22Rik, through PI3K-dependent signaling pathways. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is an inhibitor of MEK, which is part of the MAPK/ERK pathway. MEK inhibition by U0126 would lead to decreased activity of downstream kinases, which could include protein 1500003O22Rik if it is involved in this pathway. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 is an inhibitor of Src family tyrosine kinases. If protein 1500003O22Rik is activated by Src kinase signaling, PP2 would inhibit this activation by blocking Src kinase activity. | ||||||